The Centers for Disease Control and Prevention Foundation has partnered with Indianapolis-based global pharmaceutical company Eli Lilly and Co. to expand the CDC's Safe Injection Practices Coalition.
SIPC is a group of public health, medical and industry organizations aiming to raise awareness for both patients and healthcare providers about safe injection practices through their One & Only Campaign, which seeks to prevent potential exposure to infection from unsafe injection practices and influence the patient safety culture by emphasizing "One Needle, One Syringe, Only One Time" for every injection.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
During Eli Lilly's three-year partnership with SIPC, the coalition aims to expand the reach of the One & Only Campaign, develop new training and communication materials, enhance the campaign's online and social media presence and engage and attract new SIPC members.
More Articles on Patient Safety:
To Prevent MRSA, Healthcare Workers Want Clarified Protocols
Iowa Hospitals Improve Quality Measures, Save $51M
MMR Vaccine Linked to Lower Hospital Admissions, Overall Infections